JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 102 filers reported holding JOUNCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $38,907 | +196.4% | 21,031 | +77.8% | 0.00% | – |
| Q4 2022 | $13,128 | +1212.8% | 11,827 | +5019.9% | 0.00% | – |
| Q3 2022 | $1,000 | -98.8% | 231 | -99.1% | 0.00% | – |
| Q2 2022 | $82,000 | -3.5% | 26,787 | +112.8% | 0.00% | – |
| Q1 2022 | $85,000 | -56.0% | 12,587 | -45.5% | 0.00% | – |
| Q4 2021 | $193,000 | +129.8% | 23,077 | +103.8% | 0.00% | – |
| Q3 2021 | $84,000 | -32.8% | 11,324 | -38.2% | 0.00% | – |
| Q2 2021 | $125,000 | -37.2% | 18,321 | -5.5% | 0.00% | – |
| Q1 2021 | $199,000 | +586.2% | 19,383 | +372.4% | 0.00% | – |
| Q4 2020 | $29,000 | +383.3% | 4,103 | +433.6% | 0.00% | – |
| Q3 2020 | $6,000 | -84.2% | 769 | -85.9% | 0.00% | – |
| Q2 2020 | $38,000 | -44.9% | 5,460 | -62.6% | 0.00% | – |
| Q1 2020 | $69,000 | -61.2% | 14,602 | -28.4% | 0.00% | – |
| Q4 2019 | $178,000 | +334.1% | 20,395 | +63.4% | 0.00% | – |
| Q3 2019 | $41,000 | +173.3% | 12,480 | +325.8% | 0.00% | – |
| Q2 2019 | $15,000 | +7.1% | 2,931 | +27.3% | 0.00% | – |
| Q1 2019 | $14,000 | -36.4% | 2,303 | -65.6% | 0.00% | – |
| Q4 2018 | $22,000 | -21.4% | 6,702 | +58.0% | 0.00% | – |
| Q3 2018 | $28,000 | +1300.0% | 4,241 | +1596.4% | 0.00% | – |
| Q2 2018 | $2,000 | -93.3% | 250 | -81.2% | 0.00% | – |
| Q1 2018 | $30,000 | +76.5% | 1,331 | +1.3% | 0.00% | – |
| Q4 2017 | $17,000 | +183.3% | 1,314 | +261.0% | 0.00% | – |
| Q3 2017 | $6,000 | -75.0% | 364 | -67.2% | 0.00% | – |
| Q1 2017 | $24,000 | – | 1,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
| TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
| Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
| PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
| Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
| Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
| PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
| Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |